Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand
NCT00398684Phase 3Completed
- Sponsor
- Institut de Recherche pour le Développement
- Start
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nevirapine in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Institut de Recherche pour le Développement. Primary endpoint: Definitive HIV infection in infants. Started Jan 2001; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00398684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398684.